Medisafe

Medisafe enables patients to manage their treatment journeys effectively through its advanced technology and personalized approach. Through features like the Digital Drug Companion, PATHWAYS, and Just-In-Time-Interventions technology, Medisafe supports real-time patient interaction, promotes adherence and persistence to treatment plans, and helps coordinate care seamlessly. Furthermore, Medisafe facilitates dynamic personalization, offering personalized engagement at critical stages of a patient's treatment journey.

To support patient adherence, Medisafe offers features like the Digital Drug Companion, PATHWAYS, and Just-in-Time-Interventions technology. These solutions foster patient support and adherence to treatment plans by timely patient interaction and efficient care management. Also, dynamic personalization provides personalized engagement at key moments along the treatment journey, thus promoting adherence.

The Digital Drug Companion feature serves as a vital support system for patients in Medisafe. It aids in managing treatment plans, providing patients with the necessary support for treatment adherence, and streamlines medication procurement processes. The Digital Drug Companion also facilitates real-time understanding into treatment behaviors, enabling enhanced care coordination and patient support.

Medisafe's Just-In-Time-Interventions (JITI) technology works by enabling timely and personalized interactions with patients, helping to support and improve treatment adherence and persistence. The JITI technology identifies key moments during a patient's treatment journey to engage and provide relevant interventions, ensuring efficient management of medication schedules, dosage tracking, and overall treatment.

Yes, Medisafe can assist in clinical trial retention. Medisafe's platform offers well-curated features to support and enhance clinical trial retention. By increasing patient adherence, enabling personalized patient engagement, and providing real-time insights into treatment behavior, Medisafe aids in maintaining patient participation in clinical trials.